COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 160 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2020. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,197 | +80.5% | 1,888 | +73.5% | 0.00% | – |
| Q2 2023 | $23,381 | -97.5% | 1,088 | -97.2% | 0.00% | -100.0% |
| Q1 2023 | $945,254 | +2853.9% | 39,402 | +2089.0% | 0.00% | – |
| Q2 2020 | $32,000 | +28.0% | 1,800 | +20.0% | 0.00% | – |
| Q1 2020 | $25,000 | +2400.0% | 1,500 | +1707.2% | 0.00% | – |
| Q1 2019 | $1,000 | -97.7% | 83 | -97.2% | 0.00% | – |
| Q3 2018 | $43,000 | -86.4% | 2,926 | -76.4% | 0.00% | -100.0% |
| Q1 2018 | $316,000 | +618.2% | 12,373 | +417.0% | 0.00% | – |
| Q4 2017 | $44,000 | +41.9% | 2,393 | -4.3% | 0.00% | – |
| Q2 2017 | $31,000 | +675.0% | 2,500 | +525.0% | 0.00% | – |
| Q1 2017 | $4,000 | -93.4% | 400 | -89.7% | 0.00% | -100.0% |
| Q4 2016 | $61,000 | – | 3,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 1,926,283 | $40,105,000 | 3.74% |
| Camber Capital Management LP | 4,000,000 | $83,280,000 | 2.20% |
| FRAZIER MANAGEMENT LLC | 943,666 | $19,647,000 | 1.76% |
| MANGROVE PARTNERS IM, LLC | 593,741 | $12,362,000 | 1.56% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 303,685 | $6,323,000 | 1.07% |
| Eventide Asset Management | 2,427,976 | $50,550,000 | 0.99% |
| Avidity Partners Management LP | 1,000,400 | $20,828,000 | 0.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,108,219 | $23,073,000 | 0.93% |
| Perceptive Advisors | 2,058,068 | $42,849,000 | 0.63% |
| Rock Springs Capital Management LP | 1,175,000 | $24,464,000 | 0.62% |